Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 16, 2005 01:00 ET | Source: Actelion Ltd.

American College of Rheumatology Poster Presentation Highlights Clinical Data About bosentan In Systemic Sclerosis Patients Suffering From Digital Ulceration

SAN DIEGO, Nov. 16, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ATLN) announced today the poster presentation at the American College of Rheumatology (ACR) of results of RAPIDS-2, a...
November 01, 2005 01:00 ET | Source: Actelion Ltd.

First Ever Placebo-Controlled Trial to Show Benefits in Eisenmenger's Syndrome Presented at CHEST

MONTREAL, Nov. 1, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) announced that the results from the first ever placebo-controlled study in patients with Eisenmenger's syndrome are...
October 26, 2005 20:00 ET | Source: Actelion Ltd.

One-Year Results on the Use of Miglustat -- Zavesca -- in Niemann Pick Type C Presented at the Annual Conference of the American Society of Human Genetics

ALLSCHWIL, Switzerland, Oct. 26, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) announced today a poster presentation at the annual conference of the American Society of Human Genetics...
October 19, 2005 20:14 ET | Source: Actelion Ltd.

CORRECTING and REPLACING -- Actelion Announces 9-Month Results for 2005

ALLSCHWIL, Switzerland, Oct. 19, 2005 (PRIMEZONE) -- Due to a transposition error, the Actelion 9-months 2005 press release contained two errors in terms of Tracleer sales numbers. Tracleer sales for...
October 19, 2005 11:55 ET | Source: Actelion Ltd.

Actelion Announces 9-Month Results for 2005

ALLSCHWIL, Switzerland, Oct. 19, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first nine months of 2005. With total net revenues for the first nine months...
September 08, 2005 01:00 ET | Source: Actelion Ltd.

Actelion Hosts its 3rd Research and Development Day

ALLSCHWIL, Switzerland, Sept. 8, 2005 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) today provided a comprehensive overview of its preclinical and clinical pipeline at its 3rd R&D...
September 05, 2005 01:03 ET | Source: Actelion Ltd.

Tracleer Excellence Post Marketing Surveillance Programme -- TRAX PMS -- Confirms Long-Term Safety Profile in Various Pulmonary Arterial Hypertension Subgroups

STOCKHOLM, Sweden, Sept. 5, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) announced today that two abstracts presented at the European Society of Cardiology (ESC) conference confirm the long-term...
August 16, 2005 11:35 ET | Source: Actelion Ltd.

Actelion Ltd.: JACC Publication on Tracleer in Children with PAH

ALLSCHWIL, Switzerland, Aug. 16, 2005 (PRIMEZONE) -- Actelion Ltd. (Other OTC:ALIOF) (SWX:ATLN) announced today that the Journal of the American College of Cardiology (JACC) has published a new study...
August 09, 2005 01:00 ET | Source: Actelion Ltd.

Actelion: Second Study with bosentan (Tracleer) Demonstrating a Statistically Significant Reduction of New Digital Ulcers in Patients with Systemic Sclerosis

ALLSCHWIL, Switzerland, Aug. 9, 2005 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX: ATLN) announced today the preliminary result of a double-blind, placebo-controlled, randomized, multi-center,...
July 28, 2005 01:16 ET | Source: Actelion Ltd.

Actelion Announces Half-Year Financial Results 2005

ALLSCHWIL/BASEL, Switzerland, July 28, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced its financial results for the first six months of 2005. With total net revenue for...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right